Josh J Carlson

12PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersDisease surveillanceMedical biotechnology diagnostics (incl. biosensors)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 01, 2026
Real-World Comparative Effectiveness of Abiraterone, Apalutamide, Enzalutamide, and Docetaxel Doublets for Metastatic Hormone-Sensitive Prostate Cancer.

|Jul 06, 2026
Molecular Testing in Primary Advanced or Recurrent Endometrial Cancer: A Cost-Effectiveness Analysis.

|Mar 28, 2025
Real-World Molecular Testing Rates and Patterns in Patients With Primary Advanced or Recurrent Endometrial Cancer in the United States.

Yilin Chen, Solomon J Lubinga, Troy Williams

|Aug 22, 2022
Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic NTRK gene fusion cancers.

Kangho Suh, Josh J Carlson, Fang Xia

|Mar 31, 2022
Key learnings from Institute for Clinical and Economic Review's real-world evidence reassessment pilot.

Ashley Jaksa, Lisa Bloudek, Josh J Carlson

|Nov 12, 2021
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer.

Josh J Carlson, Gregory F Guzauskas, Robert A Dann

Pageof 2

Frequent Collaborators

3 joint publications

Scott Ramsey

2 joint publications

Kangho Suh

2 joint publications

Anirban Basu

2 joint publications

Solomon J Lubinga